Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: another step forward.
Kaplan
M M
MM
Bonis
P A L
PA
D019819:Budesonide / Q000627:therapeutic use*; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000517:prevention & control; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy*; D017093:Liver Failure / Q000517:prevention & control; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D002756:Cholagogues and Choleretics; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D019819:Budesonide; D014580:Ursodeoxycholic Acid; D009173:Mycophenolic Acid